Literature DB >> 21628073

Phosphatidylserine inhibits NFκB and p38 MAPK activation in human monocyte derived dendritic cells.

Kara Doffek1, Xiao Chen, Sonia L Sugg, Joel Shilyansky.   

Abstract

Phosphatidylserine (PS) is an anionic phospholipid restricted to the inner surface of the plasma membrane. PS translocates to the cell surface during early apoptosis where it serves as a marker for rapid uptake by phagocytes. PS is also thought to regulate immune responses. Dendritic cells (DC) are the most potent antigen presenting cells. Previous studies demonstrated that PS inhibits the expression of MHC and co-stimulatory molecules, the secretion of IL-12p70, and the ability to activate T cells by human monocyte derived DCs. However, the cell signaling mechanisms by which PS regulated DCs are not well described. In the current study we tested the effects of PS on signal transduction pathways thought to regulate human myeloid DC maturation and IL-12p70 production. We showed that PS inhibited the activation of nuclear factor-κB (NFκB) in response to LPS by preventing IκBα phosphorylation and degradation. PS also increased the total IκBα levels in immature DCs and inhibited p38 mitogen activated protein kinase (MAPK) phosphorylation and activation. The findings suggest a possible mechanism for regulating the immunostimulatory function of DCs by PS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628073     DOI: 10.1016/j.molimm.2011.04.021

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  ATP11B deficiency leads to impairment of hippocampal synaptic plasticity.

Authors:  Jiao Wang; Weihao Li; Fangfang Zhou; Ruili Feng; Fushuai Wang; Shibo Zhang; Jie Li; Qian Li; Yajiang Wang; Jiang Xie; Tieqiao Wen
Journal:  J Mol Cell Biol       Date:  2019-08-19       Impact factor: 6.216

2.  Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis.

Authors:  Weifan Yin; Song Ouyang; Zhaohui Luo; Qiuming Zeng; Bo Hu; Liqun Xu; Yuan Li; Bo Xiao; Huan Yang
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 3.  Mechanisms of red blood cell transfusion-related immunomodulation.

Authors:  Kenneth E Remy; Mark W Hall; Jill Cholette; Nicole P Juffermans; Kathleen Nicol; Allan Doctor; Neil Blumberg; Philip C Spinella; Philip J Norris; Mary K Dahmer; Jennifer A Muszynski
Journal:  Transfusion       Date:  2018-01-30       Impact factor: 3.157

4.  Dying cell clearance and its impact on the outcome of tumor radiotherapy.

Authors:  Kirsten Lauber; Anne Ernst; Michael Orth; Martin Herrmann; Claus Belka
Journal:  Front Oncol       Date:  2012-09-11       Impact factor: 6.244

5.  Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway.

Authors:  Xian Jin; Tongqing Yao; Zhong'e Zhou; Jian Zhu; Song Zhang; Wei Hu; Chengxing Shen
Journal:  Biomed Res Int       Date:  2015-05-31       Impact factor: 3.411

6.  Advanced Glycation End Products Enhance Murine Monocyte Proliferation in Bone Marrow and Prime Them into an Inflammatory Phenotype through MAPK Signaling.

Authors:  Xian Jin; Liang Liu; Yaping Zhang; Yin Xiang; Guizhi Yin; Yi Lu; Ludong Shi; Jian Dong; Chengxing Shen
Journal:  J Diabetes Res       Date:  2018-03-22       Impact factor: 4.011

7.  Erythromycin Suppresses the Cigarette Smoke Extract-Exposed Dendritic Cell-Mediated Polarization of CD4+ T Cells into Th17 Cells.

Authors:  Jifeng Liu; Xiaoning Zhong; Zhiyi He; Jianquan Zhang; Jing Bai; Guangnan Liu; Yi Liang; Leilei Ya; Xianglin Qin
Journal:  J Immunol Res       Date:  2020-01-21       Impact factor: 4.818

Review 8.  TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy.

Authors:  Adam S Dayoub; Rolf A Brekken
Journal:  Cell Commun Signal       Date:  2020-02-22       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.